These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33634546)

  • 1. Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach.
    Xu MM; Zhou MT; Li SW; Zhen XC; Yang S
    J Neurosci Res; 2021 May; 99(5):1308-1324. PubMed ID: 33634546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoproteomics in neurodegenerative diseases.
    Hwang H; Zhang J; Chung KA; Leverenz JB; Zabetian CP; Peskind ER; Jankovic J; Su Z; Hancock AM; Pan C; Montine TJ; Pan S; Nutt J; Albin R; Gearing M; Beyer RP; Shi M; Zhang J
    Mass Spectrom Rev; 2010; 29(1):79-125. PubMed ID: 19358229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry based glycoproteomics--from a proteomics perspective.
    Pan S; Chen R; Aebersold R; Brentnall TA
    Mol Cell Proteomics; 2011 Jan; 10(1):R110.003251. PubMed ID: 20736408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers.
    Kobeissy F; Kobaisi A; Peng W; Barsa C; Goli M; Sibahi A; El Hayek S; Abdelhady S; Ali Haidar M; Sabra M; Orešič M; Logroscino G; Mondello S; Eid AH; Mechref Y
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.
    Nayak A; Salt G; Verma SK; Kishore U
    Int Rev Neurobiol; 2015; 121():59-86. PubMed ID: 26315762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein glycosylation and glycoinformatics for novel biomarker discovery in neurodegenerative diseases.
    Costa J; Hayes C; Lisacek F
    Ageing Res Rev; 2023 Aug; 89():101991. PubMed ID: 37348818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroproteomics tools in clinical practice.
    Shevchenko G; Konzer A; Musunuri S; Bergquist J
    Biochim Biophys Acta; 2015 Jul; 1854(7):705-17. PubMed ID: 25680928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative glycoproteomics: approaches and applications.
    Wei X; Li L
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):104-13. PubMed ID: 19091783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning and Digital Biomarkers Can Detect Early Stages of Neurodegenerative Diseases.
    Chudzik A; Śledzianowski A; Przybyszewski AW
    Sensors (Basel); 2024 Feb; 24(5):. PubMed ID: 38475108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case for protein-level and site-level specificity in glycoproteomic studies of disease.
    Schumacher KN; Dodds ED
    Glycoconj J; 2016 Jun; 33(3):377-85. PubMed ID: 27007620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics in neurodegenerative disorders.
    Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
    Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential of Proteomics in Understanding Neurodegeneration.
    Pal R; Larsen JP; Moller SG
    Int Rev Neurobiol; 2015; 121():25-58. PubMed ID: 26315761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the Properties and Functions of Glycoproteins Using Quantitative Proteomics.
    Xu S; Xu X; Wu R
    J Proteome Res; 2023 Jun; 22(6):1571-1588. PubMed ID: 37010087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insight into neurodegeneration: the role of proteomics.
    Pal R; Alves G; Larsen JP; Møller SG
    Mol Neurobiol; 2014 Jun; 49(3):1181-99. PubMed ID: 24323427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein glycosylation in urine as a biomarker of diseases.
    Xu M; Yang A; Xia J; Jiang J; Liu CF; Ye Z; Ma J; Yang S
    Transl Res; 2023 Mar; 253():95-107. PubMed ID: 35952983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.
    Abou-Abbass H; Abou-El-Hassan H; Bahmad H; Zibara K; Zebian A; Youssef R; Ismail J; Zhu R; Zhou S; Dong X; Nasser M; Bahmad M; Darwish H; Mechref Y; Kobeissy F
    Electrophoresis; 2016 Jun; 37(11):1549-61. PubMed ID: 26957254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.
    Heywood WE; Galimberti D; Bliss E; Sirka E; Paterson RW; Magdalinou NK; Carecchio M; Reid E; Heslegrave A; Fenoglio C; Scarpini E; Schott JM; Fox NC; Hardy J; Bhatia K; Heales S; Sebire NJ; Zetterberg H; Mills K
    Mol Neurodegener; 2015 Dec; 10():64. PubMed ID: 26627638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of glycoproteins in human cerebrospinal fluid.
    Hwang HJ; Quinn T; Zhang J
    Methods Mol Biol; 2009; 566():263-76. PubMed ID: 20058177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.